Product NDC: | 42023-120 |
Proprietary Name: | Triostat |
Non Proprietary Name: | liothyronine sodium |
Active Ingredient(s): | 10 ug/mL & nbsp; liothyronine sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42023-120 |
Labeler Name: | JHP Pharmaceuticals LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020105 |
Marketing Category: | NDA |
Start Marketing Date: | 20071001 |
Package NDC: | 42023-120-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (42023-120-01) > 1 mL in 1 VIAL, SINGLE-USE |
NDC Code | 42023-120-01 |
Proprietary Name | Triostat |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (42023-120-01) > 1 mL in 1 VIAL, SINGLE-USE |
Product NDC | 42023-120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | liothyronine sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20071001 |
Marketing Category Name | NDA |
Labeler Name | JHP Pharmaceuticals LLC |
Substance Name | LIOTHYRONINE SODIUM |
Strength Number | 10 |
Strength Unit | ug/mL |
Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |